SIREN : 892074618
TROMP MEDICAL is a French company founded 5 years ago, specialized in the sector Réparation de matériels électroniques et optiques. Based in BRIE-COMTE-ROBERT (77170), this company of category PME shows in 2024 a revenue of 9.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 9 501 504 € | 9 173 237 € | 9 229 692 € | 7 604 483 € |
| Net income | 56 039 € | 525 392 € | 394 263 € | 961 452 € |
| EBITDA | 347 094 € | 267 615 € | 564 246 € | 654 792 € |
| Net margin | 0.6% | 5.7% | 4.3% | 12.6% |
In 2024, TROMP MEDICAL achieves revenue of 9.5 M€. Over the period 2021-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +7.7%. Vs 2023: +4%. After deducting consumption (4.4 M€), gross margin stands at 5.1 M€, i.e. a rate of 53%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 347 k€, representing 3.7% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 56 k€, i.e. 0.6% of revenue. This profit can be retained or distributed to shareholders.
9 501 504 €
5 080 380 €
347 094 €
113 890 €
56 039 €
3.7%
The debt ratio (= Financial debt / Equity x 100) stands at 72%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 2.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
72.387%
12.334%
2.717%
1.848
11.1%
In 2024, the debt ratio of TROMP MEDICAL (72.39) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of TROMP MEDICAL (12.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
In 2024, the repayment capacity of TROMP MEDICAL (1.85) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 302.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.8x. Coverage is limited: any activity downturn would jeopardize interest payments.
302.488
1.814
In 2024, the liquidity ratio of TROMP MEDICAL (302.49) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of TROMP MEDICAL (1.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 101 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 25 days. The gap of 76 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 21 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 140 days of revenue, i.e. 3.7 M€ to permanently finance.
3 701 501 €
101 j
25 j
21 j
140 j
Based on 197 transactions of similar company sales (all years), the value of TROMP MEDICAL is estimated at 1 254 536 € (range 551 150€ - 2 558 639€). With an EBITDA of 347 094€, the sector multiple of 2.4x is applied. The price/revenue ratio is 0.28x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 197 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare TROMP MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Réparation de matériels électroniques et optiques
The revenue of TROMP MEDICAL in 2024 is 9.5 M€.
Yes, TROMP MEDICAL generated a net profit of 56 k€ in 2024.
The headquarters of TROMP MEDICAL is located in BRIE-COMTE-ROBERT (77170), in the department Seine-et-Marne.
The tax return of TROMP MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
TROMP MEDICAL operates in the sector Réparation de matériels électroniques et optiques (NAF code 33.13Z). See the 'Sector positioning' section above to compare the company with its competitors.